Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1982 Oct;41(5):458–462. doi: 10.1136/ard.41.5.458

Serum copper and erythrocyte superoxide dismutase in rheumatoid arthritis.

J C Banford, D H Brown, R A Hazelton, C J McNeil, R D Sturrock, W E Smith
PMCID: PMC1001022  PMID: 7125714

Abstract

Serum copper and thiol levels an caeruloplasmin activity were determined and compared with measurements of articular index, erythrocyte sedimentation rate, and zinc and haemoglobin levels in patients with rheumatoid arthritis. Superoxide dismutase activity, thiol, zinc, and copper levels of haemolysate were measured and compared with each other and to the above parameters. In serum, caeruloplasmin activity increased and thiol levels decreased, whereas in the haemolysate superoxide dismutase activity decreased and thiol levels increased. It is suggested that the changes in copper levels and in the activities of process which may be copper-dependent between plasma and cytosol in patients with rheumatoid arthritis reflect a change in oxidative status of the blood which may have implications in the pathogenesis of the disease.

Full text

PDF
458

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albergoni V., Cassini A. The oxidation of cysteine by ceruloplasmin. FEBS Lett. 1975 Jul 15;55(1):261–264. doi: 10.1016/0014-5793(75)81006-4. [DOI] [PubMed] [Google Scholar]
  2. Brown D. H., Buchanan W. W., el-Ghobarey A. F., Smith W. E., Teape J. Serum copper and its relationship to clinical symptoms in rheumatoid arthritis. Ann Rheum Dis. 1979 Apr;38(2):174–176. doi: 10.1136/ard.38.2.174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brown D. H., Smith W. E., Teape J. W., Lewis A. J. Antiinflammatory effects of some copper complexes. J Med Chem. 1980 Jul;23(7):729–734. doi: 10.1021/jm00181a006. [DOI] [PubMed] [Google Scholar]
  4. Concetti A., Massei P., Rotilio G., Brunori M., Rachmilewitz E. A. Superoxide dismutase in red blood cells: method of assay and enzyme content in normal subjects and in patients with beta-thalassemia (major and intermedia). J Lab Clin Med. 1976 Jun;87(6):1057–1064. [PubMed] [Google Scholar]
  5. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association. Ann Rheum Dis. 1959 Mar;18(1):49–53. [PMC free article] [PubMed] [Google Scholar]
  6. ELLMAN G. L. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959 May;82(1):70–77. doi: 10.1016/0003-9861(59)90090-6. [DOI] [PubMed] [Google Scholar]
  7. Goetzl E. J., Falchuk K. H., Zeiger L. S., Sullivan A. L., Hebert C. L., Adams J. P., Decker J. L. A physiological approach to the assessment of disease activity in rheumatoid arthritis. J Clin Invest. 1971 Jun;50(6):1167–1180. doi: 10.1172/JCI106594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gutteridge J. M. Caeruloplasmin: a plasma protein, enzyme, and antioxidant. Ann Clin Biochem. 1978 Nov;15(6):293–296. doi: 10.1177/000456327801500170. [DOI] [PubMed] [Google Scholar]
  9. Hagenfeldt L., Arvidsson A., Larsson A. Glutathione and gamma-glutamylcysteine in whole blood, plasma and erythrocytes. Clin Chim Acta. 1978 Apr 17;85(2):167–173. doi: 10.1016/0009-8981(78)90236-x. [DOI] [PubMed] [Google Scholar]
  10. Huber C. T., Frieden E. Substrate activation and the kinetics of ferroxidase. J Biol Chem. 1970 Aug 10;245(15):3973–3978. [PubMed] [Google Scholar]
  11. Kamel H., Teape J., Brown D. H., Ottaway J. M., Smith W. E. Determination of copper in plasma ultrafiltrate by atomic-absorption spectrometry using carbon furnace atomisation. Analyst. 1978 Sep;103(1230):921–927. doi: 10.1039/an9780300921. [DOI] [PubMed] [Google Scholar]
  12. Kingston I. B., Kingston B. L., Putnam F. W. Chemical evidence that proteolytic cleavage causes the heterogeneity present in human ceruloplasmin preparations. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5377–5381. doi: 10.1073/pnas.74.12.5377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  14. McMurray W., Martin V. M., Scudder P., Stocks J., White A. G., Dormandy T. L. Urinary copper excretion in rheumatoid arthritis. Ann Rheum Dis. 1975 Aug;34(4):340–345. doi: 10.1136/ard.34.4.340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Michel R. G., Hall M. L., Ottaway J. M., Fell G. S. Determination of cadmium in blood and urine by flame atomic-fluorescence spectrometry. Analyst. 1979 Jun;104(1239):491–504. doi: 10.1039/an9790400491. [DOI] [PubMed] [Google Scholar]
  16. Misra H. P., Fridovich I. Superoxide dismutase: a photochemical augmentation assay. Arch Biochem Biophys. 1977 May;181(1):308–312. doi: 10.1016/0003-9861(77)90509-4. [DOI] [PubMed] [Google Scholar]
  17. Reed D. W., Passon P. G., Hultquist D. E. Purification and properties of a pink copper protein from human erythrocytes. J Biol Chem. 1970 Jun 10;245(11):2954–2961. [PubMed] [Google Scholar]
  18. Rydén L., Björk I. Reinvestigation of some physicochemical and chemical properties of human ceruloplasmin (ferroxidase). Biochemistry. 1976 Aug 10;15(16):3411–3417. doi: 10.1021/bi00661a003. [DOI] [PubMed] [Google Scholar]
  19. Scudder P. R., Al-Timimi D., McMurray W., White A. G., Zoob B. C., Dormandy T. L. Serum copper and related variables in rheumatoid arthritis. Ann Rheum Dis. 1978 Feb;37(1):67–70. doi: 10.1136/ard.37.1.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Scudder P., Stocks J., Dormandy T. L. The relationship between erythrocyte superoxide dismutase activity and erythrocyte copper levels in normal subjects and in patients with rheumatoid arthritis. Clin Chim Acta. 1976 Jun 15;69(3):397–403. doi: 10.1016/0009-8981(76)90111-x. [DOI] [PubMed] [Google Scholar]
  21. Sorenson J. R. Copper chelates as possible active forms of the antiarthritic agents. J Med Chem. 1976 Jan;19(1):135–148. doi: 10.1021/jm00223a024. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES